PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

NCT05852873 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Post COVID-19 Condition, Unspecified
SARS-CoV2 Infection
COVID-19

Interventions

DRUG: Nirmatrelvir/ritonavir
DRUG: Placebo

Sponsor

Haukeland University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]